For the Inventor, By the Inventor

Enter assignee name

Research Triangle Park, NC, United States of America

Grifols Therapeutics Inc.

USPTO Granted Patents = 26

CIPO Patents = 4

EPO Patents = 17

Trademarks = 14

Forward Citations = 69

Loading Chart...

Loading Chart...

47 inventors (with patents filed for the assignee):

Valery Novokhatny (7 out of 12 patents)

Danuta Wronska (4 out of 9 patents)

Jennifer Audrey Hunt (4 out of 7 patents)

4. Thomas P Zimmerman (3 out of 14 patents)

5. James Rebbeor (2 out of 8 patents)

6. Anthony Klos (2 out of 5 patents)

7. Jianxin Guo (2 out of 39 patents)

8. Brett Buno (2 out of 4 patents)

9. Marco Grebe (2 out of 2 patents)

10. Deborah Barnette (2 out of 2 patents)

11. Katherine Schouest (2 out of 2 patents)

12. Edward Koepf (2 out of 6 patents)

13. Philip Scuderi, Jr (2 out of 2 patents)

14. Mark Cornell Manning (1 out of 84 patents)

15. Charles Miller (1 out of 6 patents)

26 patents: Sort by Forward Citations

1. 10113206 - Methods, compositions, and kits for determining human immunodeficiency virus (HIV) (2018-10-30),

2. 9921229 - Immunochromatography devices, methods, and kits (2018-03-20),

3. 9879246 - Reversibly inactivated acidified plasmin composition (2018-01-30),

4. 9616126 - Composition, method, and kit for alpha-1 proteinase inhibitor (2017-04-11),

5. 9598739 - Human erythrovirus (2017-03-21),

6. 9512493 - Compositions, methods, and kits for nucleic acid hybridization (2016-12-06),

7. 9290820 - Methods for detection of parvovirus B19 (2016-03-22),

8. 9273366 - Methods, compositions, and kits for determining human immunodeficiency virus (HIV) (2016-03-01),

9. 9206410 - Compositions, methods and kits for preparing plasminogen and plasmin prepared therefrom (2015-12-08),

10. 9121857 - Immunochromatography devices, methods and kits (2015-09-01),

11. 8852585 - Method of treatment and prophylaxis of diseases related to amyloid deposition using IgM (2014-10-07),

12. 8840637 - Therapeutic delivery devices, systems, and methods (2014-09-23),

13. 8772461 - Two-stage ultrafiltration/diafiltration (2014-07-08),

14. 8759293 - von Willebrand factor (vWF)-containing preparations, and methods, kits, and uses related thereto (2014-06-24),

15. 8648177 - Lyophilization methods, compositions, and kits (2014-02-11),

Grifols Therapeutics Inc. is a global healthcare company focused on improving the health and well-being of people around the world. With a long history dating back to 1940, Grifols is dedicated to advancing patient care through the development and production of innovative plasma-derived medicines and biological products. They specialize in therapeutic treatments for rare and chronic diseases, including immunoglobulins, albumin, coagulation factors, and alpha-1 antitrypsin. Grifols operates state-of-the-art manufacturing facilities and laboratories to ensure the highest quality standards. Their commitment to scientific research and collaboration with healthcare professionals continues to drive medical advancements and enhance the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

26 Patents

#17 in Research Triangle Park, NC

#292 in North Carolina

#12,451 in US

#24,093 in the World

Research Triangle Park, NC, United States of America

Grifols Therapeutics Inc.

Forward Citations = 69

47 inventors:

Valery Novokhatny (7 out of 12 patents)

Danuta Wronska (4 out of 9 patents)

Jennifer Audrey Hunt (4 out of 7 patents)

4. Thomas P Zimmerman (3 out of 14 patents)

5. James Rebbeor (2 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…